ACG 2022
Yield Not Always High, but Results Still Meaningful In Pancreatic Cancer Screening
Although the yield may be less than expected, pancreas screening can detect high-risk lesions in time for ...
JULY 6, 2023

Managing Bloating and Distension: Detective Work to Find the Solution
For patients who truly have trouble handling gas, bloating and distension can affect everything from the fit of ...
JUNE 14, 2023

For the Patient With Advanced Adenomas, UCSF Program Communicates Risk to Relatives
First-degree relatives of people with advanced adenomas have an increased risk for colorectal cancer, yet this risk ...
MAY 17, 2023

Risankizumab Data Back Use in Moderate To Severe Crohn’s Disease
Risankizumab appears to be effective in treating the symptoms of moderate to severe Crohn’s disease ...
MAY 15, 2023

Registry Data Show Vedolizumab, Ustekinumab Safe in Pregnancy
Patients being treated with vedolizumab or ustekinumab for inflammatory bowel disease who are pregnant or are ...
APRIL 5, 2023

Novel Use of Artificial Intelligence Shows Promise to Improve HCC Detection
An innovative use of artificial intelligence to find hepatocellular carcinoma could identify even small and ...
MARCH 31, 2023

Treating Chronic Diarrhea: A Stepwise Approach to a Common Problem
Chronic diarrhea affects 5% of the U.S. population and is a condition that gastroenterologists see every day.
MARCH 30, 2023

Key Recommendations from AGA Conference on the Future of AI in GI
Ashish Atreja, MD, MPH, highlights artificial intelligence advances discussed at ACG 2022.
MARCH 25, 2023

Advantages Shown for Endoscopic Management of Necrotizing Pancreatitis
Endoscopic management of necrotizing pancreatitis has multiple advantages over surgery, according to a recent ...
MARCH 23, 2023

Endoscopic Sleeve Gastroplasty May Have Advantages Over Balloon
Patients who underwent ESG had slightly more weight loss, while those undergoing IGB saw a high rate of early ...
MARCH 9, 2023

Bile Acid Sequestrants Found Effective for Refractory Microscopic Colitis
Bile acid sequestrants effectively treat microscopic colitis that is refractory to standard therapies, according to ...
MARCH 8, 2023

More Data Support Dupilumab for Severe EoE
Dupilumab improves eosinophilic esophagitis, with benefits sustained to 52 weeks, according to updated analyses of ...
MARCH 3, 2023
